Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Ferro

Showing results (21-30 of 127) with videos related to

Pageof 13
Sort By:
JRSM Cardiovascular Disease|December 7, 2020
Netrin-1: Focus on its role in cardiovascular physiology and atherosclerosisVasco Claro, Albert Ferro
British Journal of Clinical Pharmacology|February 7, 2013
Nutraceuticals: is there good science behind the hype?Jeroen Schmitt, Albert Ferro
JRSM Cardiovascular Disease|February 27, 2014
Aldosterone synthase inhibitors in hypertension: current status and future possibilitiesMilan Hargovan, Albert Ferro
Journal of Biomedical Research|January 30, 2014
Renal denervation as an option for the management of hypertensionGeorgina Radhini Santiapillai, Albert Ferro
JRSM Cardiovascular Disease|November 1, 2013
The platelet fibrinogen receptor: from megakaryocyte to the mortuaryChristopher N Floyd, Albert Ferro
British Journal of Clinical Pharmacology|January 24, 2014
Drugs for addiction: a therapeutic area in need of a 'shot in the arm'Andrea L Malizia, Albert Ferro
British Journal of Clinical Pharmacology|July 10, 2013
The PlA1/A2 polymorphism of glycoprotein IIIa in relation to efficacy of antiplatelet drugs: a systematic review and meta-analysisChristopher N Floyd, Albert Ferro
BMJ (Clinical Research Ed.)|October 7, 2017
Indications for anticoagulant and antiplatelet combined therapyChristopher N Floyd, Albert Ferro
British Journal of Clinical Pharmacology|January 21, 2015
From an evolutionary perspective, all 'new' antimicrobial targets are old: time to think outside the boxJennifer H Martin, Albert Ferro
Pharmacology & Therapeutics|September 3, 2013
Mechanisms of aspirin resistanceChristopher N Floyd, Albert Ferro
Pageof 13

Showing results (21-30 of 127) with videos related to

Sort By:
Pageof 13
JRSM Cardiovascular Disease|December 7, 2020
Netrin-1: Focus on its role in cardiovascular physiology and atherosclerosisVasco Claro, Albert Ferro
British Journal of Clinical Pharmacology|February 7, 2013
Nutraceuticals: is there good science behind the hype?Jeroen Schmitt, Albert Ferro
JRSM Cardiovascular Disease|February 27, 2014
Aldosterone synthase inhibitors in hypertension: current status and future possibilitiesMilan Hargovan, Albert Ferro
Journal of Biomedical Research|January 30, 2014
Renal denervation as an option for the management of hypertensionGeorgina Radhini Santiapillai, Albert Ferro
JRSM Cardiovascular Disease|November 1, 2013
The platelet fibrinogen receptor: from megakaryocyte to the mortuaryChristopher N Floyd, Albert Ferro
British Journal of Clinical Pharmacology|January 24, 2014
Drugs for addiction: a therapeutic area in need of a 'shot in the arm'Andrea L Malizia, Albert Ferro
British Journal of Clinical Pharmacology|July 10, 2013
The PlA1/A2 polymorphism of glycoprotein IIIa in relation to efficacy of antiplatelet drugs: a systematic review and meta-analysisChristopher N Floyd, Albert Ferro
BMJ (Clinical Research Ed.)|October 7, 2017
Indications for anticoagulant and antiplatelet combined therapyChristopher N Floyd, Albert Ferro
British Journal of Clinical Pharmacology|January 21, 2015
From an evolutionary perspective, all 'new' antimicrobial targets are old: time to think outside the boxJennifer H Martin, Albert Ferro
Pharmacology & Therapeutics|September 3, 2013
Mechanisms of aspirin resistanceChristopher N Floyd, Albert Ferro
Pageof 13